CGEN Q3 2025 Earnings — Compugen Ltd. Revenue & Financial Results | Market Cap Arena

CGENCompugen Ltd.

$202M

Q3 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-89.0% YoY

Gross Profit

$241,00012.7% margin

Operating Income

-$8M-417.4% margin

Net Income

-$7M-369.1% margin

EPS (Diluted)

$-0.07

QoQ Revenue Growth

+50.4%

Cash Flow

Operating Cash Flow

$0

Free Cash Flow

$0

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$98M

Total Liabilities

$54M

Stockholders' Equity

$44M

Cash & Equivalents

$7M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$17M	-89.0%
Gross Profit	$241,000	$14M	-98.2%
Operating Income	-$8M	$4M	-275.6%
Net Income	-$7M	$1M	-646.9%